Core Laboratories (CLB) Accounts Payables (2022 - 2026)

Core Laboratories' Accounts Payables history runs 5 years deep, the most recent figure standing at $40.0 million for Q1 2026.

• On a quarterly basis, Accounts Payables rose 3.86% year-over-year to $40.0 million in Q1 2026; TTM through Mar 2026 was $40.0 million, a 3.86% increase from a year earlier, with the FY2025 full-year figure at $37.3 million, up 7.89% from the prior year.
• Accounts Payables grew to $40.0 million in Q1 2026 per CLB's latest filing, from $37.3 million in the prior quarter.
• Across five years, Accounts Payables topped out at $45.8 million in Q4 2022 and bottomed at $32.5 million in Q1 2024.
• The 5-year median for Accounts Payables is $36.9 million (2025), against an average of $37.3 million.
• Across the five-year window, Accounts Payables slipped 26.92% in 2023 and rose 18.5% in 2025, its largest moves.
• Year by year, Accounts Payables stood at $45.8 million in 2022, then declined by 26.92% to $33.5 million in 2023, then advanced by 3.11% to $34.5 million in 2024, then grew by 7.89% to $37.3 million in 2025, then gained by 7.26% to $40.0 million in 2026.
• Per Business Quant, the three latest CLB Accounts Payables figures stand at $40.0 million (Q1 2026), $37.3 million (Q4 2025), and $36.9 million (Q3 2025).